von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
about
Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpuraStructure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpuraHemolytic uremic syndrome: new developments in pathogenesis and treatmentAntibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpuraPathophysiology of thrombotic thrombocytopenic purpuraDifferent disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromesVon Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraCurrent concepts in thrombotic thrombocytopenic purpuraPathogenesis of thrombotic microangiopathiesHemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimersAggrecanases and cartilage matrix degradationClinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in KoreaADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural OverviewProteolytic processing of von Willebrand factor by adamts13 and leukocyte proteasesPrinciples of separation: indications and therapeutic targets for plasma exchange.Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndromeThe role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpuraADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpuraRelevance of ADAMTS13 to liver transplantation and surgeryIs severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? YesIs ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? NoThe von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP)Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in ratsShigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from JapanThe European Hematology Association Roadmap for European Hematology Research: a consensus documentAllosteric activation of ADAMTS13 by von Willebrand factor.Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage.A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.Therapeutic plasma exchange and renal related vasculitis: therapeutic apheresis academy 2010.Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.Flow-driven assembly of VWF fibres and webs in in vitro microvesselsConcomitant thrombotic thrombocytopenic purpura and ANCA-associated vasculitis in an adolescent.Attack of the acronyms: TTP, VWF, ADAMTS-13 and SELDI-TOF-MS.A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry.Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse.Thrombotic thrombocytopenic purpura today.Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?Induction of microthrombotic thrombocytopenia in normal mice by transferring a platelet-reactive, monoclonal anti-gp70 autoantibody established from MRL/lpr mice: an autoimmune model of thrombotic thrombocytopenic purpura.Plasma exchange as successful treatment of thrombotic thrombocytopenic purpura post autologous bone marrow transplant in a child.
P2860
Q24241470-957403CD-0A42-4D42-9EC0-37A59E6323B1Q24291691-91B81B78-DFC3-495B-B1A8-8519C46C95BAQ24613517-3F442AD3-1BB3-4672-8ABC-3572CAA9DCA4Q24614077-DE4A0F2B-63FB-4C58-B747-1BCF16B27D60Q24614117-D582268B-688F-4AC9-BC1C-E47A64F2146EQ24616851-BD7E282C-5228-426A-AA47-45959EB8216CQ24651320-07D0EAF0-C7DF-4B52-9059-A44266A16F19Q24656680-521EC81F-665C-4313-A0EF-C4757528191AQ24658043-BB2017AA-F046-4AAA-B6CE-E176C2871684Q24669689-DE098938-6633-4A1E-9AEE-1573CA820A9BQ24804310-E9238544-CF0F-4F5C-9A18-002024A957D8Q26739894-34EAF3C2-932F-4F5B-9BB4-775F995D8B67Q26747656-432E413D-20CB-4093-A340-7D7F3AE72300Q26827966-02215018-DC76-4077-92A4-BAC642C5D3F4Q26830899-864A33DA-6C43-48BE-BBA8-071DDE081263Q28067041-4BE0997A-10B7-483E-B00C-5F8BAEF457C4Q28080631-3D6DFC3B-9A68-4DB2-8FBC-5C36C3B5F827Q28083264-B25DBCB1-08A1-44FF-9B5A-3803E1B14A0BQ28085109-A26EDB4E-AFD9-4B19-B289-47EA99F57A95Q28188189-C2815C80-14F3-4670-A13E-AF050A6177C7Q28188198-D77B4668-6590-400D-B1FE-A3DC3D98B7A1Q28305837-36BE3C20-76C1-45CC-B967-1351C87F87D2Q28577463-6B0CF770-FD84-4504-B670-294FF05BE1E6Q28594414-406D222D-12CB-4A59-BFE3-02EE58CA6DF6Q28731380-8C31064C-8EA9-4B13-8AEF-017211FBBA28Q28830861-AD1D10C4-87A2-4DF3-95BF-D126415095DBQ29568910-829FB1BA-5EB0-47F9-94AE-2418622A4EE2Q30405809-7425F407-92C1-4CCC-B9FF-FA9A9D71A54DQ30441694-98A82171-AA31-47FD-9D6D-B515845FC7E1Q30454083-506EADB1-A0AA-44B8-A5C4-976596B4E6AAQ30543370-503A131E-C228-42A9-B417-18579ED19490Q30659684-1F4C1DD2-CA30-4B3A-80BD-58C5E9ECEF5EQ33159947-642D4719-B847-4154-A9B1-236EC9734F7FQ33231921-D65C1853-CCFB-4C77-80AC-D487A3813D81Q33231922-2E682CB6-8F21-4DA4-82E7-82BAC2752869Q33327295-E72CF366-0FD7-4963-8DF7-A2A8C6333C11Q33329549-B5E7A0E2-30C9-4D76-8181-4EAD6573A7CFQ33330004-7DFDD1F7-7885-438D-B7B6-426B12B62A4FQ33331009-FF49F74C-5D51-4EBC-8C90-EB5D93CC0B4BQ33331909-133C7A30-3227-4395-B7A6-8EBC0E07DABD
P2860
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
von Willebrand factor-cleaving ...... the hemolytic-uremic syndrome.
@ast
von Willebrand factor-cleaving ...... the hemolytic-uremic syndrome.
@en
type
label
von Willebrand factor-cleaving ...... the hemolytic-uremic syndrome.
@ast
von Willebrand factor-cleaving ...... the hemolytic-uremic syndrome.
@en
prefLabel
von Willebrand factor-cleaving ...... the hemolytic-uremic syndrome.
@ast
von Willebrand factor-cleaving ...... the hemolytic-uremic syndrome.
@en
P2093
P1476
von Willebrand factor-cleaving ...... the hemolytic-uremic syndrome.
@en
P2093
I Scharrer
M Galbusera
M Solenthaler
P304
P356
10.1056/NEJM199811263392202
P407
P577
1998-11-01T00:00:00Z